ArticleJournal of oncology practice2017
Discussing Health Care Expenses in the Oncology Clinic: Analysis of Cost Conversations in Outpatient Encounters.
Article in Journal of oncology practice, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03780491 (Understanding and Addressing Patient and Provider Preferences Around Discussions of Cost of Breast Cancer Care), which is not on this map. Cited by 42 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Understanding and Addressing Patient and Provider Preferences Around Discussions of Cost of Breast Cancer Care
Who cites it
42 citing papers in PubMed.
- Not all cost conversations are the same: An exploration of potential value in cost conversations during Atrial fibrillation treatment decision making.Patient education and counseling · 2024Trial
- The impact of adding cost information to a conversation aid to support shared decision making about low-risk prostate cancer treatment: Results of a stepped-wedge cluster randomised trial.Health expectations : an international journal of public participation in health care and health policy · 2023Trial
- Capturing Financial Burden Concerns in an ALS Multidisciplinary Clinic.Muscle & nerve · 2026Article
- Communication of Cost in Thyroidectomy: A Mixed-Methods Analysis of Financial Toxicity.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026Article
- Insights into Cancer Patients' Experiences and Needs in the Northeast Region of India: A Qualitative Study.Healthcare (Basel, Switzerland) · 2025Article
- Article
- Physician knowledge, practice patterns, and barriers encountered regarding guideline-concordant use of bone modifying agents for prostate cancer.The Prostate · 2024Article
- Financial Toxicity in Breast Reconstruction: The Role of the Surgeon-Patient Cost-of-Care Discussion.Seminars in plastic surgery · 2024Review
- Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity.Current atherosclerosis reports · 2023Review
- Financial burden and recommended multilevel solutions among caregivers of pediatric hematopoietic stem cell transplant recipients.Pediatric blood & cancer · 2023Article
- Use of Drugs in Clinical Practice and the Associated Cost of Cancer Treatment in Adult Patients with Solid Tumors: A 10-Year Retrospective Cohort Study.Current oncology (Toronto, Ont.) · 2023Article
- Cost-Related Medication Nonadherence and Desire for Medication Cost Information Among Adults Aged 65 Years and Older in the US in 2022.JAMA network open · 2023Article
- Patients want to talk about their out-of-pocket costs-Can real-time benefit tools help?Journal of the American Geriatrics Society · 2023Article
- Patient perceptions of copay card utilization and policies.Journal of market access & health policy · 2023Article
- The DISCO App: A pilot test of a multi-level intervention to reduce the financial burden of cancer through improved cost communication.PEC innovation · 2022Article
- Financial Toxicity Interventions in Hematologic Malignancies Are Timely and Necessary.JCO oncology practice · 2022Article
- Cancer-Related Care Costs and Employment Disruption: Recommendations to Reduce Patient Economic Burden as Part of Cancer Care Delivery.Journal of the National Cancer Institute. Monographs · 2022Article
- Practical Strategies for Advanced Practitioners Streamlining the Integration of Oncology Biosimilar Therapies Into Practice.Journal of the advanced practitioner in oncology · 2022Review
- Discussion of costs and financial burden in clinical practice: A survey of medical oncologists in Australia.PloS one · 2022Article
- Parent Preferences for Transparency of Their Child's Hospitalization Costs.JAMA network open · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeASCO identified oncologist-patient conversations about cancer costs as an important component of high-quality care. However, limited data exist characterizing the content of these conversations. We sought to provide novel insight into oncologist-patient cost conversations by determining the content of cost conversations in breast cancer clinic visits.
methodsWe performed content analysis of transcribed dialogue from 677 outpatient appointments for breast cancer management. Encounters featured 677 patients with breast cancer visiting 56 oncologists nationwide from 2010 to 2013.
resultsCost conversations were identified in 22% of visits (95% CI, 19 to 25) and had a median duration of 33 seconds (interquartile range, 19 to 62). Fifty-nine percent of cost conversations were initiated by oncologists (95% CI, 51 to 67), who most commonly brought up costs for antineoplastic agents. By contrast, patients most frequently brought up costs for diagnostic tests. Thirty-eight percent of cost conversations mentioned cost-reducing strategies (95% CI, 30 to 46), which most commonly sought to lower patient costs for endocrine therapies and symptom-alleviating treatments. The three most commonly discussed cost-reducing strategies were: switching to a lower-cost therapy/diagnostic, changing logistics of the intervention, and facilitating copay assistance.
conclusionWe identified cost conversations in approximately one in five breast cancer visits. Cost conversations were mostly oncologist initiated, lasted < 1 minute, and dealt with a wide range of health care expenses. Cost-reducing strategies were mentioned in more than one third of cost conversations and often involved switching antineoplastic agents for lower-cost alternatives or altering logistics of diagnostic tests.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.